Clinic Medical Director David Bick, MD, sat down with Clinical OMICs magazine to discuss the use of next-generation sequencing (NGS) for the identification and treatment of rare disease.

“We are rapidly reaching the point where we do whole genome sequencing on anybody you think has a rare disease,” said Bick.

Read the full story on page 26.